ArticleFrontiers in cellular and infection microbiology2023

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis.

Chunli Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.